Page 1 of 152
BMTCN TEST EXAM A, B & C WITH 500 QUESTIONS
AND WELL ELABORATED ANSWERS LATEST UPDATE
THIS YEAR
BMTCN TEST EXAM A
Which of the following is not a role of a caregiver?
1) Provide physical and emotional support
2) Assist with recovery following HSCT
3) Assist with medication administration
4) Recommend OTC medications for the management of post-transplant symptoms
Recommend OTC medications for the management of post-transplant symptoms
Which option best outlines the process of auto stem cell transplants?
1) Stem cell mobilization and collection, reinfusion of auto stem cells, and administration of
high-dose chemo
2) Disease reassessment to determine remission status; stem cell mobilization, collection and
cryopreservation; administration of conditioning regimen; verification of stem cell viability;
and reinfusion of auto stem cells
3) Stem cell mobilization, collection, and cryopreservation; administration of conditioning
regimen; and reinfusion of auto stem cells
4) Disease reassessment to determine remission status; stem cell mobilization, collection, and
cryopreservation; administration of conditioning regimen; verification of stem cell viability;
and reinfusion of allogenic stem cells
Disease reassessment to determine remission status; stem cell mobilization, collection and
cryopreservation; administration of conditioning regimen; verification of stem cell viability; and
reinfusion of auto stem cells
Which treatment allows for greater use of haploidentical stem cell transplants?
1) Donor lymphocyte infusion
2) Pre-transplant cyclophosphamide
3) GVHD treatment
4) Post-transplant cyclophosphamide
Post-transplant cyclophosphamide
, Page 2 of 152
Post-transplant cyclophos depletes alloreactive T cells which has lead to same overall survival
for haplo and unrelated donors
A patient is receiving an allogenic stem cell transplant to treat AML. Which is not a donor
option for this treatment?
1) Matched unrelated donor
2) Haploidentical donor
3) Patient
4) UCB
Patient
In what situation would stem cells from an UCB donor be the best option?
1) The recipient is 58 yers old, has no children, has an older sibling in poor health, has poor
unrelated donor search prognosis, and weigh 251 lbs
2) The recipient is 49 years old, has two children, has a younger HLA matched sibling, has a
poor unrelated donor search prognosis, and weighs 137 lbs
3) The recipient is 62 years old, has no children, has no living parents or siblings, has an
excellent unrelated donor search prognosis, and weighs 251 lbs
4) The recipient is 53 years old, has no children, has an older sibling in poor health, has a poor
unrelated donor search prognosis, and weighs 137 lbs
The recipient is 53 years old, has no children, has an older sibling in poor health, has a poor
unrelated donor search prognosis, and weighs 137 lbs
A 74 year old male with AML will need an allogenic transplant. His son is his only potential
donor and a haploidentical match. He will need post-transplant cyclophosphamide, which can
be cardiotoxic. What factor(s) may affect his ability to proceed to transplant?
1) Age
2) Male gender
3) EF of 40%
4) 1 & 2
5) 1 & 3
6) All of the above
1 & 3 (age and EF of 40%)
Which of the following is an example of a myeloid cell?
1) T cells
2) B cells
3) Monocytes
4) NK cells
Monocytes
, Page 3 of 152
Which factor does not affect immune reconstitution following HSCT?
1) The recipient's response to conditioning regimen
2) Viral infections
3) Chronic GVHD
4) Longevity of mature lymphocytes present at the time of transplant
Viral infections
Hematopoiesis occurs primarily in which area?
1) Bone marrow
2) Spleen
3) Thymus gland
4) Lymph nodes
Bone marrow
Which of the following statements is true about innate immunity?
1) It occurs in response to T cell activation
2) It occurs in response to B cell activation
3) It is a natural process that uses phagocytes that release inflammatory mediators in
response to infections or illness
4) It is a natural process that occurs primarily in the spleen
It is a natural process that uses phagocytes that release inflammatory mediators in response to
infections or illness
Which is not a common indication for allogenic transplant?
1) AML
2 MDS
3) CML
4) Breast cancer
Breast cancer
Graft-vs-tumor effect is promoted by which of the following?
1) Withdrawal of immunosuppressive therapy
2) Administration of donor lymphocyte infusion
3) 1 & 2
4) Increased dose of immunosuppressive therapy
A & B (withdrawal of immunosuppressive & administration of DLI)
A 26 year old female was diagnosed with HL three years ago. At that time, she missed
multiple appointments and had trouble managing her anti-nausea medications. With her
relapse, she began salvage chemotherapy but again missed appointments to check her lab
tests. Which of the following will be the most important aspect of the recipient evaluation?
, Page 4 of 152
1) Echocardiogram
2) Diet and exercise
3) Adherence
4) CBC
Adherence
What is the most important item to consider when providing education?
1) Providing the patient with all the information they need
2) Providing a variety of materials in different learning styles
3) Tailoring education to the patient's individualized treatment plan and health literacy
4) Making sure the patient understands everything they were told
Tailoring education to the patient's individualized treatment plan and health literacy
A patient is ready to start their transplant preparative regimen. The nurse has completed
pretransplant education and wants to ensure the patient has understood their teaching. What
would be the best method to determine this?
1) Nurse ends the teaching session by asking the patient if they have additional questions
2) Nurse asks the patient to respond back in their own words what the nurse discussed
3) Nurses ask the patient if they would be willing to explain this to another patient
4) Nurse feels confident the patient understood because they asked good questions already
Nurse asks the patient to respond back in their own words what the nurse discussed
A caregiver reports feeling overwhelmed, having difficulty sleeping, and being unsure of what
they should do. What is the best way to respond to this caregiver?
1) Encourage them to focus on the patient and tell them their most important role is to care
for the transplant recipient right now
2) Provide them with a list of the tasks they are supposed to be completing
3) Provide the caregiver with a list of websites or support groups
4) Encourage the caregiver to prioritize self-care and work with the caregiver to identify the
most helpful resources and interventions
Encourage the caregiver to prioritize self-care and work with the caregiver to identify the most
helpful resources and interventions
Donor suitability and eligibility refer to which of the following?
1) What preparative regimen is most effective for a specific malignant diagnosis
2) Healthy interpersonal relationship that exists between donor and recipient
3) Donor being evaluated to determine if it is safe for them to undergo stem cell donation and
if there is minimal risk of transferring infection or disease to the recipient
4) ABO compatible donors
BMTCN TEST EXAM A, B & C WITH 500 QUESTIONS
AND WELL ELABORATED ANSWERS LATEST UPDATE
THIS YEAR
BMTCN TEST EXAM A
Which of the following is not a role of a caregiver?
1) Provide physical and emotional support
2) Assist with recovery following HSCT
3) Assist with medication administration
4) Recommend OTC medications for the management of post-transplant symptoms
Recommend OTC medications for the management of post-transplant symptoms
Which option best outlines the process of auto stem cell transplants?
1) Stem cell mobilization and collection, reinfusion of auto stem cells, and administration of
high-dose chemo
2) Disease reassessment to determine remission status; stem cell mobilization, collection and
cryopreservation; administration of conditioning regimen; verification of stem cell viability;
and reinfusion of auto stem cells
3) Stem cell mobilization, collection, and cryopreservation; administration of conditioning
regimen; and reinfusion of auto stem cells
4) Disease reassessment to determine remission status; stem cell mobilization, collection, and
cryopreservation; administration of conditioning regimen; verification of stem cell viability;
and reinfusion of allogenic stem cells
Disease reassessment to determine remission status; stem cell mobilization, collection and
cryopreservation; administration of conditioning regimen; verification of stem cell viability; and
reinfusion of auto stem cells
Which treatment allows for greater use of haploidentical stem cell transplants?
1) Donor lymphocyte infusion
2) Pre-transplant cyclophosphamide
3) GVHD treatment
4) Post-transplant cyclophosphamide
Post-transplant cyclophosphamide
, Page 2 of 152
Post-transplant cyclophos depletes alloreactive T cells which has lead to same overall survival
for haplo and unrelated donors
A patient is receiving an allogenic stem cell transplant to treat AML. Which is not a donor
option for this treatment?
1) Matched unrelated donor
2) Haploidentical donor
3) Patient
4) UCB
Patient
In what situation would stem cells from an UCB donor be the best option?
1) The recipient is 58 yers old, has no children, has an older sibling in poor health, has poor
unrelated donor search prognosis, and weigh 251 lbs
2) The recipient is 49 years old, has two children, has a younger HLA matched sibling, has a
poor unrelated donor search prognosis, and weighs 137 lbs
3) The recipient is 62 years old, has no children, has no living parents or siblings, has an
excellent unrelated donor search prognosis, and weighs 251 lbs
4) The recipient is 53 years old, has no children, has an older sibling in poor health, has a poor
unrelated donor search prognosis, and weighs 137 lbs
The recipient is 53 years old, has no children, has an older sibling in poor health, has a poor
unrelated donor search prognosis, and weighs 137 lbs
A 74 year old male with AML will need an allogenic transplant. His son is his only potential
donor and a haploidentical match. He will need post-transplant cyclophosphamide, which can
be cardiotoxic. What factor(s) may affect his ability to proceed to transplant?
1) Age
2) Male gender
3) EF of 40%
4) 1 & 2
5) 1 & 3
6) All of the above
1 & 3 (age and EF of 40%)
Which of the following is an example of a myeloid cell?
1) T cells
2) B cells
3) Monocytes
4) NK cells
Monocytes
, Page 3 of 152
Which factor does not affect immune reconstitution following HSCT?
1) The recipient's response to conditioning regimen
2) Viral infections
3) Chronic GVHD
4) Longevity of mature lymphocytes present at the time of transplant
Viral infections
Hematopoiesis occurs primarily in which area?
1) Bone marrow
2) Spleen
3) Thymus gland
4) Lymph nodes
Bone marrow
Which of the following statements is true about innate immunity?
1) It occurs in response to T cell activation
2) It occurs in response to B cell activation
3) It is a natural process that uses phagocytes that release inflammatory mediators in
response to infections or illness
4) It is a natural process that occurs primarily in the spleen
It is a natural process that uses phagocytes that release inflammatory mediators in response to
infections or illness
Which is not a common indication for allogenic transplant?
1) AML
2 MDS
3) CML
4) Breast cancer
Breast cancer
Graft-vs-tumor effect is promoted by which of the following?
1) Withdrawal of immunosuppressive therapy
2) Administration of donor lymphocyte infusion
3) 1 & 2
4) Increased dose of immunosuppressive therapy
A & B (withdrawal of immunosuppressive & administration of DLI)
A 26 year old female was diagnosed with HL three years ago. At that time, she missed
multiple appointments and had trouble managing her anti-nausea medications. With her
relapse, she began salvage chemotherapy but again missed appointments to check her lab
tests. Which of the following will be the most important aspect of the recipient evaluation?
, Page 4 of 152
1) Echocardiogram
2) Diet and exercise
3) Adherence
4) CBC
Adherence
What is the most important item to consider when providing education?
1) Providing the patient with all the information they need
2) Providing a variety of materials in different learning styles
3) Tailoring education to the patient's individualized treatment plan and health literacy
4) Making sure the patient understands everything they were told
Tailoring education to the patient's individualized treatment plan and health literacy
A patient is ready to start their transplant preparative regimen. The nurse has completed
pretransplant education and wants to ensure the patient has understood their teaching. What
would be the best method to determine this?
1) Nurse ends the teaching session by asking the patient if they have additional questions
2) Nurse asks the patient to respond back in their own words what the nurse discussed
3) Nurses ask the patient if they would be willing to explain this to another patient
4) Nurse feels confident the patient understood because they asked good questions already
Nurse asks the patient to respond back in their own words what the nurse discussed
A caregiver reports feeling overwhelmed, having difficulty sleeping, and being unsure of what
they should do. What is the best way to respond to this caregiver?
1) Encourage them to focus on the patient and tell them their most important role is to care
for the transplant recipient right now
2) Provide them with a list of the tasks they are supposed to be completing
3) Provide the caregiver with a list of websites or support groups
4) Encourage the caregiver to prioritize self-care and work with the caregiver to identify the
most helpful resources and interventions
Encourage the caregiver to prioritize self-care and work with the caregiver to identify the most
helpful resources and interventions
Donor suitability and eligibility refer to which of the following?
1) What preparative regimen is most effective for a specific malignant diagnosis
2) Healthy interpersonal relationship that exists between donor and recipient
3) Donor being evaluated to determine if it is safe for them to undergo stem cell donation and
if there is minimal risk of transferring infection or disease to the recipient
4) ABO compatible donors
